The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Levine Evan since year 2005.
The trader's CIK number is 1199838.
At the time of this reporting, Levine Evan is the CEO & President of Adventrx Pharmaceuticals Inc .
(stock ticker symbol ANX).
See this page for all insider trading activities at Adventrx Pharmaceuticals Inc .
Note that in the past LEVINE EVAN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Levine Evan since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2006-11-13
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,000
2.63
2,630
2008-02-05
ANX
Adventrx Pharmaceuticals Inc
Purchase
5,000
.42
2,125
2008-02-04
ANX
Adventrx Pharmaceuticals Inc
Purchase
5,000
.42
2,100
2004-10-04
ANX
Adventrx Pharmaceuticals Inc
Purchase
3,000
1.19
3,570
2006-05-05
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,000
4.47
4,470
2006-05-01
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,000
5.15
5,150
2004-11-30
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,800
.86
1,548
2006-05-18
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,000
4.36
4,360
2006-01-06
ANX
Adventrx Pharmaceuticals Inc
Purchase
2,000
3.86
7,726
2006-06-19
ANX
Adventrx Pharmaceuticals Inc
Purchase
1,000
3.15
3,150
2004-10-26
ANX
Adventrx Pharmaceuticals Inc
Purchase
3,200
.93
2,976
2008-02-08
ANX
Adventrx Pharmaceuticals Inc
Purchase
5,000
.50
2,525
2005-03-22
ANX
Adventrx Pharmaceuticals Inc
Sale
3,000
1.50
4,500
2005-10-27
ANX
Adventrx Pharmaceuticals Inc
Sale
3,800
3.16
12,008
2007-10-22
ANX
Adventrx Pharmaceuticals Inc
Sale
1,000
.60
601
2006-07-24
ANX
Adventrx Pharmaceuticals Inc
Sale
1,000
2.82
2,820
2007-11-19
ANX
Adventrx Pharmaceuticals Inc
Sale
3,000
.59
1,770
2006-02-23
ANX
Adventrx Pharmaceuticals Inc
Sale
2,000
4.29
8,580
2006-01-03
ANX
Adventrx Pharmaceuticals Inc
Sale
1,200
3.22
3,864
2007-12-14
ANX
Adventrx Pharmaceuticals Inc
Purchase
60,000
.46
27,600
2007-02-06
QTXB
Quantrx Biomedical Corp
Sale
993,009
.70
695,106
2005-09-14
ANX
Adventrx Pharmaceuticals Inc
Sale
54,399
3.59
195,510
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Levine Evan
(CEO & President of Adventrx Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
